CASI icon

CASI Pharmaceuticals
CASI

Overview Fund Trends Analyst Outlook Journalist POV

25 hedge funds and large institutions have $3.33M invested in CASI Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 7 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

less funds holding

Funds holding: →

71% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 7

Holders
25
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$392K
2
+$284K
3
+$39K
4
MHP
Manatuck Hill Partners
Connecticut
+$21K
5
Northern Trust
Northern Trust
Illinois
+$19.5K

Top Sellers

1
-$78K
2
-$31K
3
-$25.2K
4
WJA
Williams Jones & Associates
New York
-$20K
5
Renaissance Technologies
Renaissance Technologies
New York
-$17.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.03M
2
$718K
3
$491K
4
$392K
5
$194K
6
$160K
7
$78K
8
$54K
9
$44K
10
$39K
11
$38K
12
$25K
13
$21K
14
$20K
15
$14K
16
$2K
17
$2K
18
$1K
19
$1K
20
–
21
–